Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
139.57m
Last Price
$4.24
52-Week Range
$2.07 - $4.98
10/28/2025 08:00 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808